Cancers with greater 5-yr survival embrace prostate and breast cancers
Thursday, 04 May 2017
Despite advances in care, males and women with a analysis of heart failure proceed to have worse survival charges than sufferers with sure common cancers, a study* revealed within the European Journal of Heart Failure exhibits.
The research included 56,658 adults in Scotland who have been receiving care in a main care setting, with a complete of 147,938 individual-years of comply with-up.
In males, heart failure was linked with worse survival than prostate most cancers and bladder most cancers, however higher survival than lung most cancers and colorectal most cancers. Five-year survival was 55.eight% for heart failure however 68.three% for prostate most cancers and 57.three% for bladder most cancers. Five-year survival was solely eight.four% for lung most cancers and 48.9% for colorectal most cancers.
In women, heart failure was linked with worse survival than breast most cancers and colorectal most cancers, however higher survival than lung most cancers and ovarian most cancers. Five-year survival for women with heart failure was 49.5%, whereas it was 77.7% for breast most cancers and 51.5% for colorectal most cancers. Lower 5-yr survival occurred with lung most cancers (10.four%) and ovarian most cancers (38.2%).
Lead writer of the research, Dr Mamas Mamas, stated: “Our study shows that despite advances in the treatment of heart failure with newer drugs and devices, mortality rates for patients with heart failure remain significant and a major public health problem. Heart failure remains as malignant as many of the common cancers.”
* Mamas MA, Sperrin M, Watson MC, et al. Do sufferers have worse outcomes in heart failure than in most cancers? A main care-based mostly cohort research with 10-year comply with-up in Scotland. European Journal of Heart Failure, first revealed three May 2017. DOI: 10.1002/ejhf.822